Cargando…

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types

Two multiplex immunoassays are routinely used to assess antibody responses in clinical trials of the 9-valent human papillomavirus (9vHPV) vaccine. The HPV6/11/16/18/31/33/45/52/58 competitive Luminex immunoassay (HPV-9 cLIA) and HPV6/11/16/18/31/33/45/52/58 total immunoglobulin G Luminex immunoassa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nolan, Katrina M., Seaton, Brent, Antonello, Joseph, Zhang, Yuhua, Cook, Lauren, Delfino, Krystyn, Rubinstein, Leonard J., Cheon, Kyeongmi, Group, Thomas, Luxembourg, Alain, Dubey, Sheri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117101/ https://www.ncbi.nlm.nih.gov/pubmed/36926984 http://dx.doi.org/10.1128/msphere.00962-21

Ejemplares similares

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial
por: Thiem, Vu Dinh, et al.
Publicado: (2021)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
por: Garland, Suzanne M., et al.
Publicado: (2022)

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up
por: Kjaer, Susanne K., et al.
Publicado: (2020)

Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine
por: Rajam, Gowrisankar, et al.
Publicado: (2022)

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus
por: Robbins, Hilary A, et al.
Publicado: (2014)

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
por: Moreira, E. D., et al.
Publicado: (2017)

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women()
por: Ruiz-Sternberg, Ángela María, et al.
Publicado: (2017)

A Broad Safety Assessment of the 9-Valent Human Papillomavirus Vaccine
por: Yih, W Katherine, et al.
Publicado: (2021)

Systemic lupus erythematosus following human papillomavirus 9-valent vaccination
por: Wan, Yuehua, et al.
Publicado: (2022)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
por: Sundaram, Maria E., et al.
Publicado: (2022)

Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
por: Belmonti, Simone, et al.
Publicado: (2019)

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries
por: Garland, S M, et al.
Publicado: (2018)

Highly Multiplexed Serology for Nonhuman Mammals
por: Schuettenberg, Alexa, et al.
Publicado: (2022)

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
por: Serrano, Beatriz, et al.
Publicado: (2012)

Safety of Human Papillomavirus 9-Valent Vaccine: A Meta-Analysis of Randomized Trials
por: Costa, Ana Paula Ferreira, et al.
Publicado: (2017)

Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up
por: Olsson, Sven-Eric, et al.
Publicado: (2020)

The HPV Serology Laboratory leads an initiative to standardize and harmonize human papillomavirus serology assays
por: Park, Isabel, et al.
Publicado: (2023)

Multiplex serological assay for establishing serological profiles of polymorphic, closely related peptide antigens
por: Bolton, Jessica, et al.
Publicado: (2021)

Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence
por: SIGNORELLI, C., et al.
Publicado: (2017)

Off-Label 9-Valent Human Papillomavirus Vaccination for Actinic Keratosis: A Case Series
por: Wenande, Emily, et al.
Publicado: (2021)

The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong
por: Cheung, Tak Hong, et al.
Publicado: (2021)

Multiplex serology demonstrate cumulative prevalence and spatial distribution of malaria in Ethiopia
por: Assefa, Ashenafi, et al.
Publicado: (2019)

Development of multiplex serological assays to detect oncoviral infections
por: Burgan, William E, et al.
Publicado: (2012)

Systematic reference sample generation for multiplexed serological assays
por: Planatscher, Hannes, et al.
Publicado: (2013)

Multiplexed High-Throughput Serological Assay for Human Enteroviruses
por: Saarinen, Niila V. V., et al.
Publicado: (2020)

SARSPLEX: Multiplex Serological ELISA with a Holistic Approach
por: Garg, Kunal, et al.
Publicado: (2022)

Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection
por: Bamford, Alasdair, et al.
Publicado: (2014)

Multiplex PCR for Rapid Detection of Genes Encoding Class A Carbapenemases
por: Hong, Sang Sook, et al.
Publicado: (2012)

Intention-to-prevent analyses for estimating human papillomavirus vaccine efficacy in clinical studies
por: Saah, Alfred, et al.
Publicado: (2017)

Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries
por: Kiatpongsan, Sorapop, et al.
Publicado: (2014)

Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes
por: Kharbanda, Elyse O., et al.
Publicado: (2021)

Systemic 9-valent human papillomavirus vaccine for recalcitrant common cutaneous warts in preparation for renal transplant
por: Wyant, W. Austin, et al.
Publicado: (2022)

Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study
por: Amend, Kandace L., et al.
Publicado: (2022)

Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case report
por: Ding, Yuan, et al.
Publicado: (2023)

A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine
por: Laratta, C. R., et al.
Publicado: (2017)

A multiplex serologic platform for diagnosis of tick-borne diseases
por: Tokarz, Rafal, et al.
Publicado: (2018)

Validation of Multiplex Serology detecting human herpesviruses 1-5
por: Brenner, Nicole, et al.
Publicado: (2018)

Multiplexed Autoantibody Signature for Serological Detection of Canine Mammary Tumours
por: Hussain, Shahid, et al.
Publicado: (2018)

Validation of Multiplex PCR and Serology Detecting Helicobacter Species in Mice
por: Butt, Julia, et al.
Publicado: (2023)

Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study
por: Rahman, Shams, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_muthu79e81a10qt6a7oc7c1vca